Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Alaunos Therapeutics, Inc. (TCRT) had Non-Operating Income/Expense of $0.05M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.01M |
|
$-4.18M |
|
-- |
|
$0.01M |
|
$4.23M |
|
$-4.22M |
|
|
Non-Operating Income/Expense |
$0.05M |
$-4.18M |
|
$-4.18M |
|
$-4.18M |
|
$-4.18M |
|
$-4.18M |
|
$-4.18M |
|
$-4.22M |
|
$-4.22M |
|
1.95M |
|
1.95M |
|
$-2.20 |
|
$-2.20 |
|
| Balance Sheet Financials | |
$1.99M |
|
$0.09M |
|
$0.98M |
|
$2.97M |
|
$0.81M |
|
-- |
|
-- |
|
$0.81M |
|
$2.15M |
|
$2.15M |
|
$2.15M |
|
2.35M |
|
| Cash Flow Statement Financials | |
$-2.87M |
|
$-0.10M |
|
$3.26M |
|
$1.09M |
|
$1.39M |
|
$0.29M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-84500.00% |
|
-84500.00% |
|
-84360.00% |
|
-83520.00% |
|
-83520.00% |
|
$-2.97M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.67 |
|
219.00 |
|
-193.96% |
|
-193.96% |
|
-140.80% |
|
-193.96% |
|
$0.92 |
|
$-1.52 |
|
$-1.47 |
|